Improved cytotoxic effects of Salmonella-producing cytosine deaminase in tumour cells

Microbial Biotechnology

Volumn 8, Issue 1, 2015, Pages 169-176

  Mesa Pereira, Beatriz ^a   Medina, Carlos ^a   Camacho, Eva María ^a   Flores, Amando ^a   Santero, Eduardo ^a  

^a UNIVERSIDAD PABLO DE OLAVIDE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE DEAMINASE; FLUCYTOSINE; FLUOROURACIL; SALICYLIC ACID; BACTERIAL PROTEIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BINDING SITE; BYSTANDER EFFECT; CELL DEATH; CELL LYSATE; CELL POPULATION; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; ENZYME SYNTHESIS; EUKARYOTIC CELL; FLOW CYTOMETRY; GENE SEQUENCE; HCT116 CELL LINE; HELA CELL LINE; NONHUMAN; PHASE CONTRAST MICROSCOPY; PLASMID; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROMOTER REGION; PROTEIN EXPRESSION; RIBOSOME; SALMONELLA; SALMONELLOSIS; START CODON; TUMOR CELL; TUMOR CELL CULTURE; BIOLOGICAL THERAPY; CELL PROLIFERATION; DRUG EFFECTS; ENZYMOLOGY; GENETICS; HUMAN; METABOLISM; NEOPLASMS; PATHOPHYSIOLOGY; TUMOR CELL LINE;

BACTERIA (MICROORGANISMS); ESCHERICHIA; SALMONELLA;

BACTERIAL PROTEINS; BIOLOGICAL THERAPY; CELL LINE, TUMOR; CELL PROLIFERATION; CYTOSINE DEAMINASE; HUMANS; NEOPLASMS; SALMONELLA;

EID: 84922708358     PISSN: 17517907     EISSN: 17517915     Source Type: Journal    
DOI: 10.1111/1751-7915.12153     Document Type: Article

References (39)

1. Agorio, C., Schreiber, F., Sheppard, M., Mastroeni, P., Fernandez, M., Martinez, M.A., and Chabalgoity, J.A. (2007) Live attenuated Salmonella as a vector for oral cytokine gene therapy in melanoma. J Gene Med 9: 416-423.
2. Barnett, S.J., Soto, L.J., 3rd, Sorenson, B.S., Nelson, B.W., Leonard, A.S., and Saltzman, D.A. (2005) Attenuated Salmonella typhimurium invades and decreases tumor burden in neuroblastoma. J Pediatr Surg 40: 993-997, discussion 997-998.
3. Bourbeau, D., Lavoie, G., Nalbantoglu, J., and Massie, B. (2004) Suicide gene therapy with an adenovirus expressing the fusion gene CD: UPRT in human glioblastomas: different sensitivities correlate with p53 status. J Gene Med 6: 1320-1332.
4. Crull, K., Bumann, D., and Weiss, S. (2011) Influence of infection route and virulence factors on colonization of solid tumors by Salmonella enterica serovar Typhimurium. FEMS Immunol Med Microbiol 62: 75-83.
5. Damon, L.E., Cadman, E., and Benz, C. (1989) Enhancement of 5-fluorouracil antitumor effects by the prior administration of methotrexate. Pharmacol Ther 43: 155-185.
6. Datsenko, K.A., and Wanner, B.L. (2000) One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA 97: 6640-6645.
7. De Angelis, P.M., Svendsrud, D.H., Kravik, K.L., and Stokke, T. (2006) Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery. Mol Cancer 5: 20.
8. Erbs, P., Regulier, E., Kintz, J., Leroy, P., Poitevin, Y., Exinger, F., etal. (2000) In vivo cancer gene therapy by adenovirus-mediated transfer of a bifunctional yeast cytosine deaminase/uracil phosphoribosyltransferase fusion gene. Cancer Res 60: 3813-3822.
9. Forbes, N.S. (2010) Engineering the perfect (bacterial) cancer therapy. Nat Rev Cancer 10: 785-794.
10. Glaab, W.E., Mitchell, L.S., Miller, J.E., Vlasakova, K., and Skopek, T.R. (2005) 5-fluorouracil forward mutation assay in Salmonella: determination of mutational target and spontaneous mutational spectra. Mutat Res 578: 238-246.
11. Harris, B.E., Manning, B.W., Federle, T.W., and Diasio, R.B. (1986) Conversion of 5-fluorocytosine to 5-fluorouracil by human intestinal microflora. Antimicrob Agents Chemother 29: 44-48.
12. Jeong, J.H., Kim, K., Lim, D., Jeong, K., Hong, Y., Nguyen, V.H., etal. (2014) Anti-tumoral effect of the mitochondrial target domain of Noxa delivered by an engineered Salmonella typhimurium. PLoS ONE 9: e80050.
13. Kim, J.M., Eckmann, L., Savidge, T.C., Lowe, D.C., Witthoft, T., and Kagnoff, M.F. (1998) Apoptosis of human intestinal epithelial cells after bacterial invasion. J Clin Invest 102: 1815-1823.
14. King, I., Bermudes, D., Lin, S., Belcourt, M., Pike, J., Troy, K., etal. (2002) Tumor-targeted Salmonella expressing cytosine deaminase as an anticancer agent. Hum Gene Ther 13: 1225-1233.
15. Koechlin, B.A., Rubio, F., Palmer, S., Gabriel, T., and Duschinsky, R. (1966) The metabolism of 5-fluorocytosine-2-14-C and of cytosine-14-C in the rat and the disposition of 5-fluorocytosine-2-14-C in man. Biochem Pharmacol 15: 435-446.
16. Kuriyama, S., Masui, K., Sakamoto, T., Nakatani, T., Kikukawa, M., Tsujinoue, H., etal. (1998) Bystander effect caused by cytosine deaminase gene and 5-fluorocytosine in vitro is substantially mediated by generated 5-fluorouracil. Anticancer Res 18: 3399-3406.
17. Lawrence, T.S., Rehemtulla, A., Ng, E.Y., Wilson, M., Trosko, J.E., and Stetson, P.L. (1998) Preferential cytotoxicity of cells transduced with cytosine deaminase compared to bystander cells after treatment with 5-flucytosine. Cancer Res 58: 2588-2593.
18. Leschner, S., and Weiss, S. (2010) Salmonella-allies in the fight against cancer. J Mol Med (Berl) 88: 763-773.
19. Leung, K.Y., and Finlay, B.B. (1991) Intracellular replication is essential for the virulence of Salmonella typhimurium. Proc Natl Acad Sci USA 88: 11470-11474.
20. Loessner, H., Endmann, A., Leschner, S., Westphal, K., Rohde, M., Miloud, T., etal. (2007) Remote control of tumour-targeted Salmonella enterica serovar Typhimurium by the use of L-arabinose as inducer of bacterial gene expression in vivo. Cell Microbiol 9: 1529-1537.
21. Lundegaard, C., and Jensen, K.F. (1999) Kinetic mechanism of uracil phosphoribosyltransferase from Escherichia coli and catalytic importance of the conserved proline in the PRPP binding site. Biochemistry 38: 3327-3334.
22. Medina, C., Camacho, E.M., Flores, A., Mesa-Pereira, B., and Santero, E. (2011) Improved expression systems for regulated expression in Salmonella infecting eukaryotic cells. PLoS ONE 6: e23055.
23. Mesa-Pereira, B., Medina, C., Camacho, E.M., Flores, A., and Santero, E. (2013) Novel tools to analyze the function of Salmonella effectors show that SvpB ectopic expression induces cell cycle arrest in tumor cells. PLoS ONE 8: e78458.
24. Meyers, M., Hwang, A., Wagner, M.W., Bruening, A.J., Veigl, M.L., Sedwick, W.D., and Boothman, D.A. (2003) A role for DNA mismatch repair in sensing and responding to fluoropyrimidine damage. Oncogene 22: 7376-7388.
25. Nemunaitis, J., Cunningham, C., Senzer, N., Kuhn, J., Cramm, J., Litz, C., etal. (2003) Pilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patients. Cancer Gene Ther 10: 737-744.
26. Nishiyama, T., Kawamura, Y., Kawamoto, K., Matsumura, H., Yamamoto, N., Ito, T., etal. (1985) Antineoplastic effects in rats of 5-fluorocytosine in combination with cytosine deaminase capsules. Cancer Res 45: 1753-1761.
27. Paesold, G., Guiney, D.G., Eckmann, L., and Kagnoff, M.F. (2002) Genes in the Salmonella pathogenicity island 2 and the Salmonella virulence plasmid are essential for Salmonella-induced apoptosis in intestinal epithelial cells. Cell Microbiol 4: 771-781.
28. Pawelek, J.M., Low, K.B., and Bermudes, D. (1997) Tumor-targeted Salmonella as a novel anticancer vector. Cancer Res 57: 4537-4544.
29. Pizzorno, G., Sun, Z., and Handschumacher, R.E. (1995) Aberrant cell cycle inhibition pattern in human colon carcinoma cell lines after exposure to 5-fluorouracil. Biochem Pharmacol 49: 553-557.
30. Polak, A., and Scholer, H.J. (1975) Mode of action of 5-fluorocytosine and mechanisms of resistance. Chemotherapy 21: 113-130.
31. Rehemtulla, A., Hamstra, D.A., Kievit, E., Davis, M.A., Ng, E.Y., Dornfeld, K., and Lawrence, T.S. (2004) Extracellular expression of cytosine deaminase results in increased 5-FU production for enhanced enzyme/prodrug therapy. Anticancer Res 24: 1393-1399.
32. Royo, J.L., Becker, P.D., Camacho, E.M., Cebolla, A., Link, C., Santero, E., and Guzman, C.A. (2007) In vivo gene regulation in Salmonella spp. by a salicylate-dependent control circuit. Nat Methods 4: 937-942.
33. Saltzman, D.A., Heise, C.P., Hasz, D.E., Zebede, M., Kelly, S.M., Curtiss, R., 3rd, etal. (1996) Attenuated Salmonella typhimurium containing interleukin-2 decreases MC-38 hepatic metastases: a novel anti-tumor agent. Cancer Biother Radiopharm 11: 145-153.
34. Takeda, H., Haisa, M., Naomoto, Y., Kawashima, R., Satomoto, K., Yamatuji, T., and Tanaka, N. (1999) Effect of 5-fluorouracil on cell cycle regulatory proteins in human colon cancer cell line. Jpn J Cancer Res 90: 677-684.
35. Vermes, A., Guchelaar, H.J., and Dankert, J. (2000) Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions. J Antimicrob Chemother 46: 171-179.
36. Westphal, K., Leschner, S., Jablonska, J., Loessner, H., and Weiss, S. (2008) Containment of tumor-colonizing bacteria by host neutrophils. Cancer Res 68: 2952-2960.
37. Yam, C., Zhao, M., Hayashi, K., Ma, H., Kishimoto, H., McElroy, M., etal. (2010) Monotherapy with a tumor-targeting mutant of S. typhimurium inhibits liver metastasis in a mouse model of pancreatic cancer. J Surg Res 164: 248-255.
38. Yoshikawa, R., Kusunoki, M., Yanagi, H., Noda, M., Furuyama, J.I., Yamamura, T., and Hashimoto-Tamaoki, T. (2001) Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy. Cancer Res 61: 1029-1037.
39. Zhao, M., Yang, M., Ma, H., Li, X., Tan, X., Li, S., etal. (2006) Targeted therapy with a Salmonella typhimurium leucine-arginine auxotroph cures orthotopic human breast tumors in nude mice. Cancer Res 66: 7647-7652.